Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging

Oxidative stress is characterized by an imbalance between prooxidant and antioxidant species, leading to macromolecular damage and disruption of redox signaling and cellular control. It is a hallmark of various diseases including metabolic syndrome, chronic fatigue syndrome, neurodegenerative, cardi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oxidative medicine and cellular longevity 2019, Vol.2019 (2019), p.1-14
Hauptverfasser: Keller-Pintér, Anikó, Dux, László, Csernoch, László, Czirják, Tamás, Gönczi, Mónika, Dienes, Beatrix, Sztretye, Mónika, Szentesi, Péter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 14
container_issue 2019
container_start_page 1
container_title Oxidative medicine and cellular longevity
container_volume 2019
creator Keller-Pintér, Anikó
Dux, László
Csernoch, László
Czirják, Tamás
Gönczi, Mónika
Dienes, Beatrix
Sztretye, Mónika
Szentesi, Péter
description Oxidative stress is characterized by an imbalance between prooxidant and antioxidant species, leading to macromolecular damage and disruption of redox signaling and cellular control. It is a hallmark of various diseases including metabolic syndrome, chronic fatigue syndrome, neurodegenerative, cardiovascular, inflammatory, and age-related diseases. Several mitochondrial defects have been considered to contribute to the development of oxidative stress and known as the major mediators of the aging process and subsequent age-associated diseases. Thus, mitochondrial-targeted antioxidants should prevent or slow down these processes and prolong longevity. This is the reason why antioxidant treatments are extensively studied and newer and newer compounds with such an effect appear. Astaxanthin, a xanthophyll carotenoid, is the most abundant carotenoid in marine organisms and is one of the most powerful natural compounds with remarkable antioxidant activity. Here, we summarize its antioxidant targets, effects, and benefits in diseases and with aging.
doi_str_mv 10.1155/2019/3849692
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6878783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A612367837</galeid><sourcerecordid>A612367837</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-573dac75b90b4dfa0ac590441793a196899723e53c130ce4b784f53eff65a0163</originalsourceid><addsrcrecordid>eNqNkU1vEzEQhi0EoqVw44wscUEqS_29aw5Iq_IpFcEhnM3E69242tjFdtry73GUkAIn5MN4NM-8M6MXoaeUvKJUyjNGqD7jndBKs3vomGrBGqK1uH_4E3KEHuV8SYjiTNCH6IjTjoqu5cfoe58L3EIoKx9e4x5_jcWF4mHGn32JdhXDkGrWLCBNrrgB97Uab_1QW_AiOSjrymMf8FufHWSXMYQB3_iywv3kw_QYPRhhzu7JPp6gb-_fLc4_NhdfPnw67y8aK7QujWz5ALaVS02WYhiBgJWaCEFbzYFq1WndMu4kt5QT68Sy7cQouRtHJYFQxU_Qm53u1Wa5doOtWyWYzVXya0g_TQRv_q4EvzJTvDaqa-vjVeDFXiDFHxuXi1n7bN08Q3Bxkw3jjHWEKSEr-vwf9DJuUqjnVYq2HVVU0jtqgtkZH8ZY59qtqOkVZVzVqW2lXu4om2LOyY2HlSkxW4PN1mCzN7jiz_488wD_drQCpzugGjrAjf9POVcZN8IdzQgXnPBfTZG2Tg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2317816151</pqid></control><display><type>article</type><title>Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging</title><source>Wiley-Blackwell Open Access Titles</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Keller-Pintér, Anikó ; Dux, László ; Csernoch, László ; Czirják, Tamás ; Gönczi, Mónika ; Dienes, Beatrix ; Sztretye, Mónika ; Szentesi, Péter</creator><contributor>Lyamzaev, Konstantin</contributor><creatorcontrib>Keller-Pintér, Anikó ; Dux, László ; Csernoch, László ; Czirják, Tamás ; Gönczi, Mónika ; Dienes, Beatrix ; Sztretye, Mónika ; Szentesi, Péter ; Lyamzaev, Konstantin</creatorcontrib><description>Oxidative stress is characterized by an imbalance between prooxidant and antioxidant species, leading to macromolecular damage and disruption of redox signaling and cellular control. It is a hallmark of various diseases including metabolic syndrome, chronic fatigue syndrome, neurodegenerative, cardiovascular, inflammatory, and age-related diseases. Several mitochondrial defects have been considered to contribute to the development of oxidative stress and known as the major mediators of the aging process and subsequent age-associated diseases. Thus, mitochondrial-targeted antioxidants should prevent or slow down these processes and prolong longevity. This is the reason why antioxidant treatments are extensively studied and newer and newer compounds with such an effect appear. Astaxanthin, a xanthophyll carotenoid, is the most abundant carotenoid in marine organisms and is one of the most powerful natural compounds with remarkable antioxidant activity. Here, we summarize its antioxidant targets, effects, and benefits in diseases and with aging.</description><identifier>ISSN: 1942-0900</identifier><identifier>EISSN: 1942-0994</identifier><identifier>DOI: 10.1155/2019/3849692</identifier><identifier>PMID: 31814873</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Acids ; Age ; Aging ; Antioxidants ; Carotenoids ; Chronic diseases ; Food ; Free radicals ; Gene expression ; Metabolism ; Metabolites ; Oxidation ; Oxidative stress ; Physiology ; Review ; Type 2 diabetes</subject><ispartof>Oxidative medicine and cellular longevity, 2019, Vol.2019 (2019), p.1-14</ispartof><rights>Copyright © 2019 Mónika Sztretye et al.</rights><rights>COPYRIGHT 2019 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2019 Mónika Sztretye et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2019 Mónika Sztretye et al. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-573dac75b90b4dfa0ac590441793a196899723e53c130ce4b784f53eff65a0163</citedby><cites>FETCH-LOGICAL-c499t-573dac75b90b4dfa0ac590441793a196899723e53c130ce4b784f53eff65a0163</cites><orcidid>0000-0002-8421-4369 ; 0000-0002-4105-8458 ; 0000-0002-2446-1456 ; 0000-0002-3110-0296 ; 0000-0003-2621-2282</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878783/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878783/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31814873$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Lyamzaev, Konstantin</contributor><creatorcontrib>Keller-Pintér, Anikó</creatorcontrib><creatorcontrib>Dux, László</creatorcontrib><creatorcontrib>Csernoch, László</creatorcontrib><creatorcontrib>Czirják, Tamás</creatorcontrib><creatorcontrib>Gönczi, Mónika</creatorcontrib><creatorcontrib>Dienes, Beatrix</creatorcontrib><creatorcontrib>Sztretye, Mónika</creatorcontrib><creatorcontrib>Szentesi, Péter</creatorcontrib><title>Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging</title><title>Oxidative medicine and cellular longevity</title><addtitle>Oxid Med Cell Longev</addtitle><description>Oxidative stress is characterized by an imbalance between prooxidant and antioxidant species, leading to macromolecular damage and disruption of redox signaling and cellular control. It is a hallmark of various diseases including metabolic syndrome, chronic fatigue syndrome, neurodegenerative, cardiovascular, inflammatory, and age-related diseases. Several mitochondrial defects have been considered to contribute to the development of oxidative stress and known as the major mediators of the aging process and subsequent age-associated diseases. Thus, mitochondrial-targeted antioxidants should prevent or slow down these processes and prolong longevity. This is the reason why antioxidant treatments are extensively studied and newer and newer compounds with such an effect appear. Astaxanthin, a xanthophyll carotenoid, is the most abundant carotenoid in marine organisms and is one of the most powerful natural compounds with remarkable antioxidant activity. Here, we summarize its antioxidant targets, effects, and benefits in diseases and with aging.</description><subject>Acids</subject><subject>Age</subject><subject>Aging</subject><subject>Antioxidants</subject><subject>Carotenoids</subject><subject>Chronic diseases</subject><subject>Food</subject><subject>Free radicals</subject><subject>Gene expression</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Oxidation</subject><subject>Oxidative stress</subject><subject>Physiology</subject><subject>Review</subject><subject>Type 2 diabetes</subject><issn>1942-0900</issn><issn>1942-0994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkU1vEzEQhi0EoqVw44wscUEqS_29aw5Iq_IpFcEhnM3E69242tjFdtry73GUkAIn5MN4NM-8M6MXoaeUvKJUyjNGqD7jndBKs3vomGrBGqK1uH_4E3KEHuV8SYjiTNCH6IjTjoqu5cfoe58L3EIoKx9e4x5_jcWF4mHGn32JdhXDkGrWLCBNrrgB97Uab_1QW_AiOSjrymMf8FufHWSXMYQB3_iywv3kw_QYPRhhzu7JPp6gb-_fLc4_NhdfPnw67y8aK7QujWz5ALaVS02WYhiBgJWaCEFbzYFq1WndMu4kt5QT68Sy7cQouRtHJYFQxU_Qm53u1Wa5doOtWyWYzVXya0g_TQRv_q4EvzJTvDaqa-vjVeDFXiDFHxuXi1n7bN08Q3Bxkw3jjHWEKSEr-vwf9DJuUqjnVYq2HVVU0jtqgtkZH8ZY59qtqOkVZVzVqW2lXu4om2LOyY2HlSkxW4PN1mCzN7jiz_488wD_drQCpzugGjrAjf9POVcZN8IdzQgXnPBfTZG2Tg</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Keller-Pintér, Anikó</creator><creator>Dux, László</creator><creator>Csernoch, László</creator><creator>Czirják, Tamás</creator><creator>Gönczi, Mónika</creator><creator>Dienes, Beatrix</creator><creator>Sztretye, Mónika</creator><creator>Szentesi, Péter</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8421-4369</orcidid><orcidid>https://orcid.org/0000-0002-4105-8458</orcidid><orcidid>https://orcid.org/0000-0002-2446-1456</orcidid><orcidid>https://orcid.org/0000-0002-3110-0296</orcidid><orcidid>https://orcid.org/0000-0003-2621-2282</orcidid></search><sort><creationdate>2019</creationdate><title>Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging</title><author>Keller-Pintér, Anikó ; Dux, László ; Csernoch, László ; Czirják, Tamás ; Gönczi, Mónika ; Dienes, Beatrix ; Sztretye, Mónika ; Szentesi, Péter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-573dac75b90b4dfa0ac590441793a196899723e53c130ce4b784f53eff65a0163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acids</topic><topic>Age</topic><topic>Aging</topic><topic>Antioxidants</topic><topic>Carotenoids</topic><topic>Chronic diseases</topic><topic>Food</topic><topic>Free radicals</topic><topic>Gene expression</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Oxidation</topic><topic>Oxidative stress</topic><topic>Physiology</topic><topic>Review</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Keller-Pintér, Anikó</creatorcontrib><creatorcontrib>Dux, László</creatorcontrib><creatorcontrib>Csernoch, László</creatorcontrib><creatorcontrib>Czirják, Tamás</creatorcontrib><creatorcontrib>Gönczi, Mónika</creatorcontrib><creatorcontrib>Dienes, Beatrix</creatorcontrib><creatorcontrib>Sztretye, Mónika</creatorcontrib><creatorcontrib>Szentesi, Péter</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oxidative medicine and cellular longevity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keller-Pintér, Anikó</au><au>Dux, László</au><au>Csernoch, László</au><au>Czirják, Tamás</au><au>Gönczi, Mónika</au><au>Dienes, Beatrix</au><au>Sztretye, Mónika</au><au>Szentesi, Péter</au><au>Lyamzaev, Konstantin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging</atitle><jtitle>Oxidative medicine and cellular longevity</jtitle><addtitle>Oxid Med Cell Longev</addtitle><date>2019</date><risdate>2019</risdate><volume>2019</volume><issue>2019</issue><spage>1</spage><epage>14</epage><pages>1-14</pages><issn>1942-0900</issn><eissn>1942-0994</eissn><abstract>Oxidative stress is characterized by an imbalance between prooxidant and antioxidant species, leading to macromolecular damage and disruption of redox signaling and cellular control. It is a hallmark of various diseases including metabolic syndrome, chronic fatigue syndrome, neurodegenerative, cardiovascular, inflammatory, and age-related diseases. Several mitochondrial defects have been considered to contribute to the development of oxidative stress and known as the major mediators of the aging process and subsequent age-associated diseases. Thus, mitochondrial-targeted antioxidants should prevent or slow down these processes and prolong longevity. This is the reason why antioxidant treatments are extensively studied and newer and newer compounds with such an effect appear. Astaxanthin, a xanthophyll carotenoid, is the most abundant carotenoid in marine organisms and is one of the most powerful natural compounds with remarkable antioxidant activity. Here, we summarize its antioxidant targets, effects, and benefits in diseases and with aging.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>31814873</pmid><doi>10.1155/2019/3849692</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-8421-4369</orcidid><orcidid>https://orcid.org/0000-0002-4105-8458</orcidid><orcidid>https://orcid.org/0000-0002-2446-1456</orcidid><orcidid>https://orcid.org/0000-0002-3110-0296</orcidid><orcidid>https://orcid.org/0000-0003-2621-2282</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1942-0900
ispartof Oxidative medicine and cellular longevity, 2019, Vol.2019 (2019), p.1-14
issn 1942-0900
1942-0994
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6878783
source Wiley-Blackwell Open Access Titles; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access
subjects Acids
Age
Aging
Antioxidants
Carotenoids
Chronic diseases
Food
Free radicals
Gene expression
Metabolism
Metabolites
Oxidation
Oxidative stress
Physiology
Review
Type 2 diabetes
title Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T03%3A28%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Astaxanthin:%20A%20Potential%20Mitochondrial-Targeted%20Antioxidant%20Treatment%20in%20Diseases%20and%20with%20Aging&rft.jtitle=Oxidative%20medicine%20and%20cellular%20longevity&rft.au=Keller-Pint%C3%A9r,%20Anik%C3%B3&rft.date=2019&rft.volume=2019&rft.issue=2019&rft.spage=1&rft.epage=14&rft.pages=1-14&rft.issn=1942-0900&rft.eissn=1942-0994&rft_id=info:doi/10.1155/2019/3849692&rft_dat=%3Cgale_pubme%3EA612367837%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2317816151&rft_id=info:pmid/31814873&rft_galeid=A612367837&rfr_iscdi=true